常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
1.64/1.00
|
|
企业价值
56.85M
|
| 资产负债 |
|
每股账面净值
7.87
|
| 现金流量 |
|
现金流量率
0.01
|
| 损益表 |
|
收益
10.30M
|
|
每股收益
0.89
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. |

9.7 
